Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Testosterone lowers chance of survival in deer
Red deer
Scientists say their research sheds light on how testosterone affects the health and survival of young animals.
Edinburgh scientists say high levels of hormone shortens lifespan

A study of wild deer has found that high levels of testosterone could be linked to lower survival rates in calves.

Scientists from the Universities of Edinburgh and Cambridge said first-born male deer with relatively high levels of the hormone are less likely to survive their first year.

High levels of testosterone is linked with lowered immunity to infection and a shortened lifespan. Coupled with a new mother's inexperience, scientists say this lowers the chance of survival.

The research team measured testosterone in blood samples from 850 newborn wild red deer on the Isle of Rum from 1996 and 2012.

Findings published in Functional Ecology suggest testosterone levels in newborn deer are linked to the mother's condition. Researchers say male deer born after an older brother had lower levels of testosterone than the other calves.

Experts are unsure as to why this may be, but suggest it could be that mothers are weakened by having male calves, as they are heavier and suckle longer than females.

Leading the study, Alyson Pavitt from the University of Edinburgh's School of Biological Sciences, said: "For adult animals such as red deer, high testosterone can increase strength and dominance but reduces immunity and longevity.

"This latest finding suggests that individuals born with high testosterone may be subject to similar costs."

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.